What will be the primary concern cited in opposition to the Biosecure Act by the end of the legislative session in 2025?
Economic impact • 25%
Diplomatic relations with China • 25%
Civil liberties concerns • 25%
Other • 25%
Statements from Senators or official opposition documents
Congress Weighs Biosecure Act to Restrict Blacklisted Chinese Biotech Firms Over DNA Collection
Dec 5, 2024, 03:39 PM
The U.S. Congress is considering the Biosecure Act, a legislative measure aimed at restricting blacklisted Chinese biotechnology firms linked to the Chinese military from operating in the United States. These companies are allegedly collecting DNA data from American citizens and using it for military experiments, including the development of bio-weapons and complex viruses. The bill has passed the House of Representatives and now awaits Senate approval. Supporters of the bill argue that it is essential for safeguarding national security, economic independence, and preventing potential threats posed by Chinese military-linked entities. Lawmakers are reportedly exploring a potential compromise to advance the legislation.
View original story
Lack of comprehensive immigration reform • 25%
Other reasons • 25%
Human rights concerns • 25%
Constitutional issues • 25%
Excessive spending • 25%
Other • 25%
Political strategy • 25%
Lack of transparency • 25%
Other reasons • 25%
Gender-affirming care provision • 25%
Critical Race Theory ban • 25%
Defense spending amount • 25%
Other • 25%
Economic concerns • 25%
Constitutional concerns • 25%
Humanitarian concerns • 25%
Pay Raise • 25%
Opting Out of Obamacare • 25%
Overall Spending • 25%
Other Provisions • 25%
Technological feasibility • 25%
Economic impact • 25%
Privacy • 25%
Security • 25%
Human safety • 25%
Animal rights • 25%
Other • 25%
Religious concerns • 25%
Mass deportation concerns • 25%
State vs. federal enforcement • 25%
Other • 25%
Indefinite detention concerns • 25%
Constitutional challenges • 25%
States' rights infringement • 25%
Public safety concerns • 25%
Other • 25%
Inflation concerns • 25%
Regulatory concerns • 25%
Technological feasibility • 25%
Economic benefits • 25%
Federal employees' unions • 25%
Democratic Party • 25%
Environmental groups • 25%
Other • 25%
Mission alignment concerns • 25%
Regulatory issues • 25%
Leadership disagreements • 25%
Financial concerns • 25%
Rejected • 25%
Postponed • 25%
Passed with amendments • 25%
Passed without amendments • 25%